Therefore, it is reasonable to assume that a decline in TNF-TNFRSF1A in non-classical monocytes causes a reduction in binding to TNF-α, giving TNF-α the opportunity to be activated by Aβ1-40, causing a series of cascading reactions that ultimately lead to AD. Here, TNFRSF1A is linked to Alzheimer disease.